S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Sciton Debuts Super MOXI Laser for Full-Body Skin Revitalization

Palo Alto-based Sciton Inc. has launched Super MOXI with High Density Delivery, an upgraded iteration of its flagship laser system designed to accelerate treatment times and expand skin-quality correction capabilities. The device utilizes a new twin-beam architecture to enable rapid, head-to-toe applications across the company’s existing mJOULE and JOULE X platforms.

Sciton Debuts Super MOXI Laser for Full-Body Skin Revitalization
Photo: Bio & News

The system features a 16W diode that doubles the speed of previous iterations, allowing practitioners to treat larger anatomical areas like the back, arms, and chest with greater efficiency. By leveraging the new HD Delivery system, providers can now integrate Super MOXI into broader treatment plans, pairing it with BBL HEROic, ClearSilk, and ProFractional technologies to offer comprehensive skin transformations.

Dr. Sherrif F. Ibrahim, a board-certified dermatologist, noted that the twin-beam architecture allows for high-density energy deposition, facilitating everything from gentle early-intervention sessions to intensive corrective protocols. For Sciton, the release represents a strategic push to meet the rising demand for body-wide aesthetic procedures. Robb Brindley, Executive Vice President of Sales & Marketing, stated that the development was driven by direct feedback from clinical practices seeking more versatile, time-efficient tools for patient care.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!